Find results that contain all of your keywords. Content filter is on. Search will return best illustrations, stock vectors and clipart.
Make it so!
You have chosen to exclude "" from your results.

Choose orientation:
Explore cartoons & images using related keywords:

janus

kinase

jak

tyrosine

cytokine

stat

jakstat

 pathway jak1 tofacitinib filgotinib rheumatoid rheuma arthritis psoriasis inflammatory bowel crohn inhibitor cancer structure peptide protein amino acid molecule polypeptide polymer atoms science scientific disease health molecular model

Janus Kinase 1 Protein. Part Of JAK-STAT Signalling Pathway And Drug Target Royalty-Free Stock Photo


Janus kinase 1 protein. Part of JAK-STAT signalling pathway and drug target Stock Photo
Download
Designed by
Title
Janus kinase 1 protein. Part of JAK-STAT signalling pathway and drug target #187039815
Description

Janus kinase 1 protein. Part of JAK-STAT signalling pathway and drug target. Atoms are represented as spheres with conventional color coding

Janus kinase 1 protein. Part of JAK-STAT signalling pathway and drug target
Janus kinase 1 protein. Part of JAK-STAT signalling pathway and drug target
Upadacitinib drug molecule. Second generation janus kinase inhibitor with selectivity for JAK1. Skeletal formula.
Baricitinib janus kinase JAK1
Upadacitinib drug molecule. Second generation janus kinase inhibitor with selectivity for JAK1. 3D rendering. Atoms are.

Upadacitinib drug molecule. Second generation janus kinase inhibitor with selectivity for JAK1. 3D rendering. Atoms are.
Upadacitinib drug molecule. Second generation janus kinase inhibitor with selectivity for JAK1. Skeletal formula.

Upadacitinib drug molecule. Second generation janus kinase inhibitor with selectivity for JAK1. 3D rendering. Atoms are.
Janus kinase 1 protein. Part of JAK-STAT signalling pathway and drug target.

Janus kinase 1 protein. Part of JAK-STAT signalling pathway and drug target.
Janus kinase 1 protein. Part of JAK-STAT signalling pathway and drug target.

Baricitinib janus kinase JAK1
Upadacitinib drug molecule. Second generation janus kinase inhibitor with selectivity for JAK1
Tofacitinib rheumatoid arthritis drug molecule. Inhibitor of Janus kinase 3 (JAK3